| P50 | author | Patrick Masson | Q42732222 |
| | Olivier Rohr | Q84032829 |
| P2093 | author name string | Christian Schwartz | |
| | Valentin Le Douce | |
| | Mikael Elias | |
| | Guillaume Gotthard | |
| | Ermanno Candolfi | |
| | Eric Chabrière | |
| | Andrea Janossy | |
| | Thomas Cherrier | |
| | Alicia Jeudy | |
| | Houda Hallay | |
| P2860 | cites work | Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) | Q22242256 |
| | Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells | Q24679559 |
| | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
| | Tandem use of X-ray crystallography and mass spectrometry to obtain ab initio the complete and exact amino acids sequence of HPBP, a human 38-kDa apolipoprotein | Q27649292 |
| | The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention | Q28251761 |
| | Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy | Q28253761 |
| | HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy | Q28339571 |
| | Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection | Q29619738 |
| | Eukaryotic DING proteins are endogenous: an immunohistological study in mouse tissues | Q33531742 |
| | Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy. | Q33541775 |
| | A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter | Q33613718 |
| | The macrophage in HIV-1 infection: from activation to deactivation? | Q33810779 |
| | Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage | Q33864438 |
| | Identification of X-DING-CD4, a new member of human DING protein family that is secreted by HIV-1 resistant CD4(+) T cells and has anti-viral activity | Q34215448 |
| | Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads | Q34312257 |
| | Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients | Q34725556 |
| | Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir | Q34726282 |
| | New anti-HIV agents and targets | Q34944447 |
| | Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells | Q35213780 |
| | Treatment of antiretroviral-drug-resistant HIV-1 infection | Q35610798 |
| | Recent status of HIV-1 gene expression inhibitors | Q36401015 |
| | HIV pharmacology: barriers to the eradication of HIV from the CNS. | Q36552753 |
| | DING proteins; novel members of a prokaryotic phosphate-binding protein superfamily which extends into the eukaryotic kingdom | Q36762926 |
| | Transcription of HIV: Tat and cellular chromatin | Q36857070 |
| | Hide-and-seek: the challenge of viral persistence in HIV-1 infection | Q36936328 |
| | Stabilization of the active form(s) of human paraoxonase by human phosphate-binding protein. | Q37010380 |
| | Drug-resistant human immunodefiency virus | Q37394247 |
| | For whom the bell tolls? DING proteins in health and disease | Q37416038 |
| | HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes | Q37607912 |
| | Antiretroviral drugs | Q37752820 |
| | Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results | Q37781803 |
| | Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation | Q38345116 |
| | HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy | Q38460522 |
| | Relative anti-HIV-1 efficacy of lamivudine and emtricitabine in vitro is dependent on cell type | Q39060526 |
| | Evidence for phosphatase activity of p27SJ and its impact on the cell cycle. | Q39864455 |
| | St. John's Wort protein, p27SJ, regulates the MCP-1 promoter | Q39958035 |
| | Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors. | Q40745355 |
| | Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus. | Q41018028 |
| | The regulation of human immunodeficiency virus type-1 gene expression | Q41150779 |
| | Structural insights and ab initio sequencing within the DING proteins family. | Q41228920 |
| | Cellular factors as alternative targets for inhibition of HIV-1. | Q41351055 |
| | Suppression of HIV‐1 transcriptional elongation by a DING phosphatase | Q41657411 |
| | Crystallization and preliminary X-ray diffraction analysis of human phosphate-binding protein | Q42860234 |
| | Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients | Q43193080 |
| | Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection. | Q43592431 |
| | p27(SJ), a novel protein in St John's Wort, that suppresses expression of HIV-1 genome | Q45888075 |
| | Elucidation of the phosphate binding mode of DING proteins revealed by subangstrom X-ray crystallography. | Q46010324 |
| | Direct phasing at low resolution of a protein copurified with human paraoxonase (PON1). | Q47350465 |
| | Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy | Q47960975 |
| | Discovery and crystallographic structure of human apolipoprotein | Q48080391 |
| | Serendipitous discovery and X-ray structure of a human phosphate binding apolipoprotein | Q48096684 |
| | Characterization of human monocyte-derived microglia-like cells | Q48483812 |
| | Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. | Q53869061 |
| | Reconstitution of catalytically competent human .zeta.-thrombin by combination of .zeta.-thrombin residues A1-36 and B1-148 and an Escherichia coli expressed polypeptide corresponding to .zeta.-thrombin residues B149-259 | Q54687426 |
| | Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. | Q55067967 |
| | Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system | Q73850558 |
| | A tale of the unexpected | Q82795242 |
| | Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PON1) and phosphate binding protein (HPBP) using hydroxyapatite chromatography | Q83088022 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 352 | |
| P577 | publication date | 2011-07-15 | |
| P1433 | published in | Virology Journal | Q7934868 |
| P1476 | title | Human-Phosphate-Binding-Protein inhibits HIV-1 gene transcription and replication | |
| P478 | volume | 8 | |